Cargando…

Crosstalk between the JAK2 and TGF-β1 signaling pathways in scleroderma-related interstitial lung disease targeted by baricitinib

BACKGROUND AND OBJECTIVE: Systemic sclerosis (SSc) is an immune-mediated rheumatic disease characterized by fibrosis and vascular lesions. Interstitial lung disease is an early complication of SSc and the main cause of death from SSc. Although baricitinib shows good efficacy in a variety of connecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Dandan, Wei, Yimei, Xu, Lulu, Zhang, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186291/ https://www.ncbi.nlm.nih.gov/pubmed/37194022 http://dx.doi.org/10.1186/s42358-023-00305-3

Ejemplares similares

Scleroderma-related interstitial lung disease
por: Suliman, Sally, et al.
Publicado: (2017)

Baricitinib Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice by Inhibiting TGF-β1 Signaling Pathway
por: Gu, Songtao, et al.
Publicado: (2023)

Paclitaxel Modulates TGFβ Signaling in Scleroderma Skin Grafts in Immunodeficient Mice
por: Liu, Xialin, et al.
Publicado: (2005)

Scar wars: is TGFβ the phantom menace in scleroderma?
por: Leask, Andrew
Publicado: (2006)

Which is the Ideal JAK Inhibitor for Alopecia Areata – Baricitinib, Tofacitinib, Ritlecitinib or Ifidancitinib - Revisiting the Immunomechanisms of the JAK Pathway
por: Sardana, Kabir, et al.
Publicado: (2023)

Interstitial lung disease in patients with scleroderma - Treatment with rituximab
por: Muñoz, A, et al.
Publicado: (2010)

Scleroderma and interstitial lung disease - A case report
por: Gul, Fahad, et al.
Publicado: (2022)

Type 2 cytokines and scleroderma interstitial lung disease
por: Pellicano, Chiara, et al.
Publicado: (2023)

Signal Transduction Pathways of EMT Induced by TGF-β, SHH, and WNT and Their Crosstalks
por: Zhang, Jingyu, et al.
Publicado: (2016)

Crosstalk between p53 and TGF-β Signalling
por: Elston, Rebecca, et al.
Publicado: (2012)

JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
por: Sanchez, Gina A. Montealegre, et al.
Publicado: (2018)

A JAK Inhibitor for Treatment of Rheumatoid Arthritis: The Baricitinib Experience
por: Taylor, Peter C., et al.
Publicado: (2023)

TGF-β Signaling in Cancer: Control by Negative Regulators and Crosstalk with Proinflammatory and Fibrogenic Pathways
por: Ungefroren, Hendrik
Publicado: (2019)

Pathway crosstalk enables cells to interpret TGF-β duration
por: Zhang, Jingyu, et al.
Publicado: (2018)

Alveolar macrophages in scleroderma lung disease are activated by TGF-β and IL-4 but not TNF-α
por: Luzina, I, et al.
Publicado: (2003)

Cross-talk between TRAIL and TGF-β in regulation of collagen production in scleroderma lung disease
por: Yurovsky, VV
Publicado: (2004)

At the Crux of Joint Crosstalk: TGFβ Signaling in the Synovial Joint
por: Bailey, Karsyn N., et al.
Publicado: (2022)

Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells
por: Liu, Chang, et al.
Publicado: (2019)

JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib
por: Traves, Paqui G, et al.
Publicado: (2021)

Defining genetic risk factors for scleroderma-associated interstitial lung disease: IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease
por: Stock, Carmel J. W., et al.
Publicado: (2020)

Increased serum levels of TGFβ1 in children with localized scleroderma
por: Uziel, Yosef, et al.
Publicado: (2007)

Successful baricitinib treatment of refractory anti‐synthetase syndrome associated with interstitial lung disease
por: Sugino, Keishi, et al.
Publicado: (2023)

Efficacy of Combination Therapy With The JAK Inhibitor Baricitinib In The Treatment of COVID-19
por: Thoms, Brendan Lawless, et al.
Publicado: (2021)

Efficacy of Combination Therapy with the JAK Inhibitor Baricitinib in the Treatment of COVID-19
por: Thoms, Brendan L., et al.
Publicado: (2022)

Safety and Tolerability of Thrombin Inhibition in Scleroderma‐Associated Interstitial Lung Disease
por: Silver, R. M., et al.
Publicado: (2019)

Targeting the NLRP3 inflammasome and associated cytokines in scleroderma associated interstitial lung disease
por: Woo, Samuel, et al.
Publicado: (2023)

Inhibition of the JAK/STAT Pathway With Baricitinib Reduces the Multiple Organ Dysfunction Caused by Hemorrhagic Shock in Rats
por: Patel, Nikita M., et al.
Publicado: (2023)

Signaling crosstalk between TGFβ and Dishevelled/Par1b
por: Mamidi, A, et al.
Publicado: (2012)

β-thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up
por: De Santis, Maria, et al.
Publicado: (2011)

Reverse crosstalk of TGFβ and PPARβ/δ signaling identified by transcriptional profiling
por: Stockert, Josefine, et al.
Publicado: (2011)

Crosstalk between 17β-Estradiol and TGF-β Signaling Modulates Glioblastoma Progression
por: Hernández-Vega, Ana M., et al.
Publicado: (2021)

Naringin attenuates renal interstitial fibrosis by regulating the TGF-β/Smad signaling pathway and inflammation
por: Wang, Ruichen, et al.
Publicado: (2021)

Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
por: Jabbari, Ali, et al.
Publicado: (2015)

Successful treatment of ulcerated pyoderma gangrenosum with baricitinib, a novel JAK inhibitor
por: Scheinberg, Morton, et al.
Publicado: (2021)

Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?
por: Yamakawa, Hideaki, et al.
Publicado: (2018)

It Takes Two to Tango: Endothelial TGFβ/BMP Signaling Crosstalk with Mechanobiology
por: Hiepen, Christian, et al.
Publicado: (2020)

Keratocyte Differentiation Is Regulated by NF-κB and TGFβ Signaling Crosstalk
por: Zhou, Xin, et al.
Publicado: (2022)

Baicalin protects against renal interstitial fibrosis in mice by inhibiting the TGF-β/Smad signalling pathway
por: Wang, Hui, et al.
Publicado: (2022)

Partially Evoked Epithelial-Mesenchymal Transition (EMT) Is Associated with Increased TGFβ Signaling within Lesional Scleroderma Skin
por: Nikitorowicz-Buniak, Joanna, et al.
Publicado: (2015)

Mycophenolate mofetil for scleroderma-related interstitial lung disease: A real world experience
por: Baqir, Misbah, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nlm1gsk03v6b065n8a07ku9pn7